SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

David Bolinsky

OncoSec Immunopulse Immunotherapy Program 

Prev Next
Previous

Neuroanatomy - Eagleman

medical illustration of  OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows a plasmid being introduced into the tumor environment where it will be adsorbed by various cells.
Next medical illustration of OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows an IL-12 coding plasmid having entered a tumor cell.

OncoSec Immunopulse Immunotherapy Program

OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows a plasmid being introduced into the tumor environment where it will be adsorbed by various cells.

Keywords:

© David Bolinsky